Cargando…
Recurrent cardiotoxicity in a fluoropyrimidine treated cancer patient – case report and practical recommendations
Fluoropyrimidines remain some of the most used chemotherapeutics, despite the appearance in the therapeutic arsenal of targeted therapy and immunotherapy. Fluropyrimidines related cardiotoxicity is an undesirable adverse event and affects almost 20% of patients. The mechanisms of fluoropyrimidine to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
UMF “Gr. T. Popa” Iasi Publishing House
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194170/ https://www.ncbi.nlm.nih.gov/pubmed/37215066 http://dx.doi.org/10.22551/2023.39.1002.10241 |